Background -Heart rate response during exercise
Background -Heart rate response during exercise and recovery is modulated by the cardiac autonomic nervous system. Because autonomic imbalance is associated with an amplified risk of death in noncongenital cardiovascular cohorts, we hypothesized that abnormal heart rate profiles may have similar prognostic implications in adult congenital heart disease (ACHD) and could be a simple means of assessing risk. Methods and Results-We analyzed 753 consecutive ACHD patients (age 33513 y, NYHA 1.720.7) with varying diagnoses and without pacemakers. Peak oxygen consumption (pVo,) and resting and peak heart rate (RHR, PHR) were measured, and heart rate reserve (HRR=PHR-RHR) was calculated. Heart rate recovery was defined as the decrease in heart rate from peak exercise to 1, 2, 3, and 5 minutes into recovery. During a median follow-up of 30.8 months (range 0.1 to 75.1), 38 (5.0%) patients died. On univariate Cox analysis, antiarrhythmic therapy and lower values of HRR, PHR, heart rate recovery, and pVo, were associated with a greater risk of death (all P<O.Ol). On ROC analysis, HRR (AUC 0.74 [95% CI 0.70 to 0.771) was superior to pVo, (AUC 0.68 [95% CI 0.65 to 0.721) in predicting mortality. On multivariate Cox analysis, HRR (hazard ratio=0.80 per 10-bpm increment in HRR [95% CI 0.70 to 0.911, P<O.OOOl) and antiarrhythmic therapy (hazard ratio=4.2 [95% CI 1.9 to 8.91, P<O.OOOl) independently predicted all-cause mortality. Stratifying patients by diagnostic groups revealed that a lower HRR was associated with a greater risk of death in patients with complex anatomy (hazard ratio=0.98 [95% CI 0.96 to 0.991, P<0.05), Fontan circulation (hazard ratio=0.96 [95% CI 0.93 to 0.99]), and tetralogy of Fallot (hazard ratio=0.96 [95% CI 0.93 to 0.991, k 0 . 0 5 ) . Conclusions-A blunted heart rate response to exercise and a delayed decrease in heart rate during recovery identify ACHD patients at an enhanced risk of mortality. In our cohort, each 10-bpm increment in heart rate reserve was associated with a 20% decrement in all-cause mortality, even after accounting for antiarrhythmic therapy and exercise capacity. Heart rate reserve could therefore represent a simple and inexpensive means of assessing risk in ACHD patients. Introduction-We previously reported no difference in surgical morbidity or mortality in infants undergoing stage 1 reconstruction (SlR) with either a modified BT shunt (mBTS) or a right ventricular-to-pulmonary artery conduit (RV-PA). We now compare the hemodynamics and perioperative course at the time of the stage 2 reconstruction (S2R) and report longer-term survival. Methods-We retrospectively reviewed the echocardiograms, catheterizations, and hospital records of all patients who had a S1R between January 2002 and May 2005, as well as cross-sectional analysis of hospital survivors. Results-One hundred seventy-six patients with HLHS and variants underwent a S1 R with either a RV-PA conduit (n=62) or a mBTS (n=114). The median duration of follow-up was 15 months (range 0 to 39). By Kaplan-Meier analysis there was no difference in survival at 3 years (RV-PA 73% [95% CL 59% to 83%] versus mBTS 69% [95% CL 59% to 77%], P=0.6). One hundred eleven patients underwent S2R (41 RV-PA and 70 mBTS). At the time of the S2R, patients with RV-PA were younger (174544 versus 190271 days, P=0.03), had lower systemic oxygen saturation (74t6% versus 77+-5%, P<O.Ol), and had higher preoperative hemoglobin levels (1 65 1.8 versus 14.85 1.9 gm/dL, P<O.Ol) compared with the mBTS group. By echo evaluation, there was a higher incidence of qualitative ventricular dysfunction in RV-PA patients (25% versus 8.3%, P<O.Ol). However, no difference was observed in common atrial pressure (8.1 t2.2 versus 8.1 t2.7 P=0.98) or the AVO2 difference (26.329.1 versus 2828.1 P=0.5). Pulmonary artery distortion was observed more frequently in the RV-PA group. At the time of the S2R, bypass time, time ventilated, and hospital length of stay were similar. For the cohort of patients undergoing a S2R, there was a trend toward an increased incidence of death or transplantation in RV-PA patients (12%) as compared with mBTS patients (6%, P=0.12) . Conclusions-Despite the initial enthusiasm for the RV-PA conduit at the S1 R, interim analyses suggest no advantage of one shunt type over another. This report raises concern of late ventricular dysfunction and outcome in patients with a RV-PA conduit. Loqger-term follow-up of a randomized patient population remains of utmost importance.
